Rani Therapeutics Holdings annual debt-to-equity ratio
2021
2022
2023
2024
2025
Rani Therapeutics Holdings Debt-to-Equity Ratio Growth & History (RANI)
Rani Therapeutics Holdings's debt-to-equity ratio was 0.13 for fiscal 2025.
View full Rani Therapeutics Holdings company overviewRani Therapeutics Holdings annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.13 | −14.78 | −99.12% |
| 2024 | 2024-12-31 | 14.91 | 12.57 | +537.51% |
| 2023 | 2023-12-31 | 2.34 | 1.52 | +185.36% |
| 2022 | 2022-12-31 | 0.82 | 0.82 | — |
| 2021 | 2021-12-31 | 0.00 | — | — |
Rani Therapeutics Holdings quarterly debt-to-equity ratio
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.09 | — | — |
| Q1 2026 | 2026-03-31 | 0.14 | — | — |
| Q4 2025 | 2025-12-31 | 0.13 | −14.78 | −99.12% |
| Q4 2024 | 2024-12-31 | 14.91 | 12.57 | +537.51% |
| Q3 2024 | 2024-09-30 | 10.81 | 9.09 | +526.69% |
| Q2 2024 | 2024-06-30 | 12.43 | 11.17 | +883.50% |
| Q1 2024 | 2024-03-31 | 4.79 | 3.79 | +380.08% |
| Q4 2023 | 2023-12-31 | 2.34 | 1.52 | +185.36% |
| Q3 2023 | 2023-09-30 | 1.73 | 1.36 | +372.89% |
| Q2 2023 | 2023-06-30 | 1.26 | 1.24 | +5950.44% |
| Q1 2023 | 2023-03-31 | 1.00 | 0.98 | +4492.25% |
| Q4 2022 | 2022-12-31 | 0.82 | 0.82 | — |
| Q3 2022 | 2022-09-30 | 0.36 | 0.36 | — |
| Q2 2022 | 2022-06-30 | 0.02 | — | — |
| Q1 2022 | 2022-03-31 | 0.02 | — | — |
| Q4 2021 | 2021-12-31 | 0.00 | — | — |
| Q3 2021 | 2021-09-30 | 0.00 | — | — |
Rani Therapeutics Holdings debt-to-equity ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Rani Therapeutics Holdings's debt-to-equity ratio increased from 0.00 to 0.13, a change of 0.13. The latest reported quarter, Q2 2026, shows 0.09.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rani Therapeutics Holdings source filings ↗